EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal‐like and malignant urothelial cells

Rebecca M Schlösser iD, Florian Krumbach, Eyleen Corrales iD, Geoffroy Andrieux iD, Christian Preisinger iD, Franziska Liss, Alexandra Golzmann, Melanie Boerries iD, Kerstin Becker iD, Ruth Knüchel iD, Stefan Garczyk, Bernhard Lüscher iD

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.70019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Rebecca M Schlösser und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany. Hauptthemen laut MEDLINE: Transcription Factors, DNA-Binding Proteins, DNA Damage, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: TRR359, CRC1160, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic regulators, such as the SWI/SNF complex, with important roles in tissue development and homeostasis, are frequently mutated in cancer. ARID1A, a subunit of the SWI/SNF complex, is mutated in approximately 20% of all bladder tumors; however, the consequences of this remain poorly understood. Finding truncations to be the most common mutation, we generated loss‐ and gain‐of‐function models to conduct RNA‐Seq, interactome analyses, Omni‐ATAC‐Seq, and functional studies to characterize ARID1A‐affected pathways potentially suitable for the treatment of ARID1A‐deficient bladder cancers. We observed decreased cell proliferation and deregulation of stress‐regulated pathways, including DNA repair, in ARID1A‐deficient cells. Furthermore, ARID1A was linked to alternative splicing and translational regulation on RNA and interactome levels. ARID1A deficiency drastically reduced the accessibility of chromatin, especially around introns and distal enhancers, in a functional enrichment analysis. Less accessible chromatin areas were mapped to pathways such as cell proliferation and DNA damage response. Indeed, the G2/M checkpoint appeared impaired after DNA damage in ARID1A‐deficient cells. Together, our data highlight the broad impact of ARID1A loss and the possibility of targeting proliferative and DNA repair pathways for treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsDNA-Binding ProteinsDNA DamageUrinary Bladder NeoplasmsUrotheliumCell CycleRNA SplicingHumansCell Line, TumorCell ProliferationAlternative SplicingGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

ARID1AATAC‐SeqDNA‐damage checkpointsRNA‐SeqSWI/SNFbladder cancer

Substanzen

Transcription FactorsARID1A protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany.
  • Institute of Medical Bioinformatics and Systems Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Proteomics Facility, Interdisciplinary Centre for Clinical Research (IZKF), Medical School, RWTH Aachen University, Aachen, Germany.
  • Institute of Biochemistry and Molecular Biology, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
  • German Cancer Consortium (DKTK), Partner Site Freiburg, a Partnership between DKFZ and Medical Center - University of Freiburg, Germany.
  • Cologne Center for Genomics (CCG), Medical Faculty, University of Cologne, Germany.

ORCID-Profile: Rebecca M Schlösser, Eyleen Corrales, Geoffroy Andrieux, Christian Preisinger, Melanie Boerries, Kerstin Becker, Ruth Knüchel, Bernhard Lüscher

Förderung

  • TRR359
  • CRC1160
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung
  • CRC1453
  • CRC1479
  • FOR5476
  • CRC/TRR167

Zitieren

APA

Schlösser, R. M., Krumbach, F., Corrales, E., Andrieux, G., Preisinger, C., Liss, F., Golzmann, A., Boerries, M., Becker, K., Knüchel, R., Garczyk, S., & Lüscher, B. (2025). Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal‐like and malignant urothelial cells. Molecular Oncology. https://doi.org/10.1002/1878-0261.70019

Vancouver

Schlösser RM, Krumbach F, Corrales E, Andrieux G, Preisinger C, Liss F, et al. Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal‐like and malignant urothelial cells. Molecular Oncology. 2025. doi:10.1002/1878-0261.70019

BibTeX
@article{Schlsser2025,
  author = {Schlösser, Rebecca M and Krumbach, Florian and Corrales, Eyleen and Andrieux, Geoffroy and Preisinger, Christian and Liss, Franziska and Golzmann, Alexandra and Boerries, Melanie and Becker, Kerstin and Knüchel, Ruth and Garczyk, Stefan and Lüscher, Bernhard},
  title = {Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal‐like and malignant urothelial cells},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.70019}
}
Kostenlos starten →